These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 26875679)

  • 61. Genome editing using Cas9 nickases.
    Trevino AE; Zhang F
    Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating strategies for reversing CRISPR-Cas9 gene drives.
    Vella MR; Gunning CE; Lloyd AL; Gould F
    Sci Rep; 2017 Sep; 7(1):11038. PubMed ID: 28887462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CRISPR/Cas9 mediated genome engineering in Drosophila.
    Bassett A; Liu JL
    Methods; 2014 Sep; 69(2):128-36. PubMed ID: 24576617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Making the cut.
    Travis J
    Science; 2015 Dec; 350(6267):1456-7. PubMed ID: 26680172
    [No Abstract]   [Full Text] [Related]  

  • 65. Time To Let CRISPR B.E.?
    Barrangou R
    CRISPR J; 2019 Apr; 2():67. PubMed ID: 30998099
    [No Abstract]   [Full Text] [Related]  

  • 66. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
    Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
    FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cas9 in close-up.
    Garside EL; MacMillan AM
    Nat Biotechnol; 2014 Apr; 32(4):338-40. PubMed ID: 24714483
    [No Abstract]   [Full Text] [Related]  

  • 68. Gene drive overdrive.
    Nat Biotechnol; 2015 Oct; 33(10):1019-21. PubMed ID: 26448078
    [No Abstract]   [Full Text] [Related]  

  • 69. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation.
    Agne M; Blank I; Emhardt AJ; Gäbelein CG; Gawlas F; Gillich N; Gonschorek P; Juretschke TJ; Krämer SD; Louis N; Müller A; Rudorf A; Schäfer LM; Scheidmann MC; Schmunk LJ; Schwenk PM; Stammnitz MR; Warmer PM; Weber W; Fischer A; Kaufmann B; Wagner HJ; Radziwill G
    ACS Synth Biol; 2014 Dec; 3(12):986-9. PubMed ID: 25524106
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evolutionary dynamics of CRISPR gene drives.
    Noble C; Olejarz J; Esvelt KM; Church GM; Nowak MA
    Sci Adv; 2017 Apr; 3(4):e1601964. PubMed ID: 28435878
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 72. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease.
    Gratz SJ; Cummings AM; Nguyen JN; Hamm DC; Donohue LK; Harrison MM; Wildonger J; O'Connor-Giles KM
    Genetics; 2013 Aug; 194(4):1029-35. PubMed ID: 23709638
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Genetic Basis of Reporter Mouse Strains.
    Kim GN; Sung YH
    Adv Exp Med Biol; 2021; 1310():551-564. PubMed ID: 33834450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiplexed CRISPR/Cas9- and TAR-Mediated Promoter Engineering of Natural Product Biosynthetic Gene Clusters in Yeast.
    Kang HS; Charlop-Powers Z; Brady SF
    ACS Synth Biol; 2016 Sep; 5(9):1002-10. PubMed ID: 27197732
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
    Amritha PP; Shah JM
    Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
    Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
    Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BIOSAFETY. Safeguarding gene drive experiments in the laboratory.
    Akbari OS; Bellen HJ; Bier E; Bullock SL; Burt A; Church GM; Cook KR; Duchek P; Edwards OR; Esvelt KM; Gantz VM; Golic KG; Gratz SJ; Harrison MM; Hayes KR; James AA; Kaufman TC; Knoblich J; Malik HS; Matthews KA; O'Connor-Giles KM; Parks AL; Perrimon N; Port F; Russell S; Ueda R; Wildonger J
    Science; 2015 Aug; 349(6251):927-9. PubMed ID: 26229113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.